Suchergebnisse - "Zhang, Lele"

PubPharm (11)

1

Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies

enthalten in: Cell | 2024

von Liu, Q. | Zhang, J. | Guo, C. | +27

CommentIn: Cell. 2024 Jan 4;187(1):14-16. - PMID 38181738

2

Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Zhang, Y. | Zhu, Y. | Chen, Y. | +9

3

Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma

enthalten in: Journal of translational medicine | 2022

von Li, D. | Yu, H. | Hu, J. | +8

4

High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer

enthalten in: Medicine | 2021

von Chen, Z. | Huang, J. | Li, M. | +3

5

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator

enthalten in: Pathology oncology research : POR | 2021

von Chen, L. | Chen, Y. | Zhang, L. | +4

6

Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China

enthalten in: Clinical lung cancer | 2020

von Zhao, Y. | Dong, Y. | Zhao, R. | +7

7

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer

enthalten in: Aging | 2020

von Zhang, M. | Zhang, L. | Li, Y. | +9

8

Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab : An ancillary analysis of the POPLAR and OAK studies

enthalten in: International journal of cancer | 2020

von Qian, J. | Nie, W. | Lu, J. | +15

9

A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer

enthalten in: BMC cancer | 2019

von Li, C. | He, X. | Zhang, L. | +2

10

Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements : Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib

enthalten in: Targeted oncology | 2019

von Zhao, Y. | Wang, S. | Zhang, B. | +5